Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

GENMAB A/S
Next earnings Aug 6, 2026 · consensus $3.48 EPS, $1.11B rev
Mixed signals in the latest filings.
GENMAB A/S shows limited reported revenue.
Sources: SEC EDGAR (CIK 0001434265, latest 6-K filed 2026-06-17) · EODHD · as of 6/22/2026, 1:43:09 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
€15/mo · cancel anytime
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1482 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.
| 2025-12-29 | GENMAB A/S 10% owner | Buy | 1.05M @ $97.00 | $102M |
| 2025-12-29 | GENMAB A/S 10% owner | Buy | 75.9M @ $97.00 | $7.36B |
| 2025-12-26 | GENMAB A/S 10% owner | Buy | 2.98K @ $97.00 | $289K |
| 2025-12-26 | GENMAB A/S 10% owner | Buy | 143K @ $97.00 | $13.8M |
| 2025-12-24 | GENMAB A/S 10% owner | Buy | 96.1K @ $97.00 | $9.32M |
| 2025-12-23 | GENMAB A/S 10% owner | Buy | 561K @ $97.00 | $54.4M |
| 2025-12-22 | GENMAB A/S 10% owner | Buy | 15.7K @ $97.00 | $1.52M |
| 2025-12-19 | GENMAB A/S 10% owner | Buy | 66.3K @ $97.00 | $6.43M |
| 2025-12-18 | GENMAB A/S 10% owner | Buy | 212K @ $97.00 | $20.6M |
| 2025-12-17 | GENMAB A/S 10% owner | Buy | 151K @ $97.00 | $14.6M |
| 2025-12-16 | GENMAB A/S 10% owner | Buy | 121K @ $97.00 | $11.7M |